Science in the Age of AI | AI for Science Forum
Eric Topol, Executive Vice President, Scripps Research, leads a conversation with:- Alison Noble, Oxford University Technikos Professor of Biomedical Enginee…
Related Articles
ONS Congress® Scholarships | Oncology Nursing Foundation
ONS Congress Scholarships are supported by the Oncology Nursing Foundation, Nancy Berkowitz Scholarship Fund, Ron Schlesinger Scholarship Fund, Oncology Hematology Care, Inc., Siouxland Chapter fund,…
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…
Conflicts of interest: moving towards zero tolerance
Harmful industries still exert their influence over health professionals, academia, and health systems; robust change is required, write Chris van Tulleken, Nigel Rollins, and Rebecca…
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…
Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma
Background: Inactivating TP53 mutations in mantle cell lymphoma (MCL) are associated with poor prognosis. While next-generation sequencing (NGS) is the gold standard for assessing TP53…
ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy
About the survey This survey aims to evaluate oncologists’ attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your participation in…
Political Language in Economics
Abstract. Does academic writing in economics reflect the political orientation of economists? We use machine learning to measure partisanship in academic e
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial
Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a…